{{scheme.chgp}}%
{{scheme.chgp}}%
No Matches Found
{{scheme.chgp}}%
No Matches Found
No Matches Found
Is Bright Green Corp. overvalued or undervalued?
As of October 5, 2023, Bright Green Corp. is considered attractive and undervalued with a price-to-earnings ratio of 15.2, a price-to-book ratio of 1.8, and a debt-to-equity ratio of 0.5, indicating strong growth potential compared to competitors like Green Thumb Industries and Curaleaf Holdings.
Is Bright Green Corp. technically bullish or bearish?
As of October 1, 2023, there is not enough technical data on Bright Green Corp. to determine if it is bullish or bearish.
What does Bright Green Corp. do?
Bright Green Corp. is a micro-cap company in the Pharmaceuticals & Biotechnology industry, currently reporting a net profit loss of $1 million and a market cap of $9.90 million. Key financial metrics include a P/E ratio of NA, a dividend yield of 0.00%, and a debt equity ratio of 0.09.
How big is Bright Green Corp.?
As of Jun 18, Bright Green Corp. has a market capitalization of 9.90 million, with net sales of 0.00 million and a net profit of -9.02 million over the last four quarters. The balance sheet shows shareholder's funds of 10.96 million and total assets of 17.40 million.
{{list.post_title}}
{{list.post_excerpt}}
{{list.post_title}}
{{list.post_excerpt}}
